1-7 of 7
Keywords: CRISPR
Close
Sort by
Articles
Biochem J (2024) 481 (12): 793–804.
Published: 17 June 2024
...Haotian Chi; Malcolm F. White CRISPR-Cas systems confer adaptive immunity in prokaryotes, facilitating the recognition and destruction of invasive nucleic acids. Type III CRISPR systems comprise large, multisubunit ribonucleoprotein complexes with a catalytic Cas10 subunit. When activated...
Includes: Supplementary data
Articles
Biochem J (2023) 480 (7): 471–488.
Published: 13 April 2023
...Tess M. McBride; Shaharn C. Cameron; Peter C. Fineran; Robert D. Fagerlund Prokaryotes have adaptive defence mechanisms that protect them from mobile genetic elements and viral infection. One defence mechanism is called CRISPR–Cas (clustered regularly interspaced short palindromic repeats...
Includes: Supplementary data
Articles
Biochem J (2020) 477 (5): 971–983.
Published: 06 March 2020
...Prakash Kalwani; Devashish Rath; Anand Ballal The cyanobacterium Anabaena PCC 7120 shows the presence of Type I-D CRISPR system that can potentially confer adaptive immunity. The Cas7 protein (Alr1562), which forms the backbone of the type I-D surveillance complex, was characterized from Anabaena...
Includes: Supplementary data
Articles
Biochem J (2018) 475 (11): 1955–1964.
Published: 11 June 2018
...Ayman Eid; Sahar Alshareef; Magdy M. Mahfouz The CRISPR (clustered regularly interspaced short palindromic repeat)/Cas9 adaptive immunity system has been harnessed for genome editing applications across eukaryotic species, but major drawbacks, such as the inefficiency of precise base editing...
Articles
Biochem J (2018) 475 (9): 1635–1642.
Published: 15 May 2018
...Glennis A. Logsdon; Ben E. Black Major advances in gene-editing technologies have enabled the rapid dissection of proteins in complex biological systems, facilitating biological experiments to complement biochemical studies with purified components. In this editorial, we highlight CRISPR/Cas9-based...
Articles
Biochem J (2017) 474 (1): 47–50.
Published: 22 December 2016
... agonists is to establish the relative pharmacological potency and efficacy of new molecules at its different target receptors, and to optimise the balance of activities to achieve the desired treatment outcome. In a recent issue of the Biochemical Journal , Naylor et al. described how they used CRISPR...
Articles